Non-statin cholesterol-lowering drugs linked to lower liver cancer risk
Certain non-statin cholesterol-lowering medications may reduce the risk of liver cancer, according to a study on Monday.
Certain non-statin cholesterol-lowering medications may reduce the risk of liver cancer, according to a study on Monday.
Using ultrasound and a blood test for high alpha fetoprotein levels together improves detection of early-stage liver cancer significantly.
Exposure to a fungal toxin – a potent carcinogen – may cause up to 80 per cent of liver cancer…
